Search results
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 1 day agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 1 day agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks· 3 days agoExelixis (EXEL) misses on earnings and sales in the first quarter. Its shares are trading down in response to the results.
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Cameron Mathison Shares Heartfelt Post as His Daughter Leila Heads to Prom: ‘Always on My Mind and...
People Magazine· 5 days agoCameron Mathison shared a tender moment with his daughter Leila as she prepared to head off to her...
The Top 3 Biotech Stocks to Buy in April 2024
InvestorPlace via Yahoo Finance· 6 days agoBiotech stocks are notorious for being some of the most volatile and unpredictable on the market. With clinical trials and FDA approvals creating...
Unknown risk factor linked to high rates of kidney cancer, DNA study finds
Medical Xpress· 1 day agoIn a paper published in Nature, scientists from the Mutographs Cancer Grand Challenges team, based at the Wellcome Sanger Institute, the International Agency for Research on Cancer, and a large ...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 12 hours agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
Retirement Systems of Alabama Sells 8,056 Shares of Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 11 hours agoRetirement Systems of Alabama cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure ...
Headlands Technologies LLC Has $32,000 Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 12 hours agoHeadlands Technologies LLC cut its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 70.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,341 shares of the biotechnology ...
